Caren van Roekel
156 Chapter 5 REFERENCES 1. Norstein J, Silen W. Natural history of liver metastases from colorectal carcinoma. J Gastrointest Surg. 1997;1(5):398-407. 2. Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer. 2002;38(7):1023-33. 3. Bengtsson G, Carlson G, Hafstrom L, Jonsson PE. Natural History of Patients With Untreated Liver Metastases From Colorectal Cancer. Am J Surg. 1981;141:586-9. 4. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244(2):254-9. 5. Engstrand J, Nilsson H, Stromberg C, Jonas E, Freedman J. Colorectal cancer liver metastases - a population-based study on incidence, management and survival. BMC Cancer. 2018;18(1):78. 6. Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, et al. NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018;16(4):359-69. 7. Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386-422. 8. Murthy R, Habbu A, Salem R. Trans- arterial hepatic radioembolisation of yttrium-90 microspheres. Biomed Im Interv J. 2006;2(3):e43. 9. Smits ML, Prince JF, Rosenbaum CE, van den Hoven AF, Nijsen JF, Zonnenberg BA, et al. Intra-arterial radioembolization of breast cancer liver metastases: a structured review. Eur J Pharmacol. 2013;709(1-3):37-42. 10. Bierman HR, Byron RL, Jr., Kelley KH, Grady A. Studies on the blood supply of tumors in man. III. Vascular patterns of the liver by hepatic arteriography in vivo. J Natl Cancer Inst. 1951;12(1):107-31. 11. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol. 1954;30(5):969-77. 12. Lien WM, Ackerman NB. The blood supply of experimental liver metastases. II. A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber. Surgery. 1970;68(2):334-40. 13. Bastiaannet R, LodgeMA, de JongH, LamM. The Unique Role of Fluorodeoxyglucose- PET in Radioembolization. PET Clin. 2019;14(4):447-57. 14. Sager S, Akgun E, Uslu-Besli L, Asa S, Akovali B, Sahin O, et al. Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma. Nucl Med Commun. 2019;40(5):461-8.
Made with FlippingBook
RkJQdWJsaXNoZXIy ODAyMDc0